NCT05555784View on ClinicalTrials.gov

Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection

CompletedOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

August 4, 2022

Primary Completion Date

February 2, 2023

Study Completion Date

February 2, 2023

Conditions

Leber's Hereditary Optic Neuropathy (LHON)

Trial Locations (1)

45160

Argo Sante, Orléans

Sponsors

Collaborators (1)

GenSight Biologics

All Listed Sponsors

collaborator

GenSight Biologics

INDUSTRY

lead

Argo Sante

OTHER